- Home
- RGS vs VYNE Comparison
RGS vs VYNE Comparison
Compare RGS & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- VYNE
- Stock Information
- Founded
- RGS 1922
- VYNE 2003
- Country
- RGS United States
- VYNE United States
- Employees
- RGS N/A
- VYNE N/A
- Industry
- RGS Other Consumer Services
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- RGS Consumer Discretionary
- VYNE Health Care
- Exchange
- RGS Nasdaq
- VYNE Nasdaq
- Market Cap
- RGS 44.6M
- VYNE 35.7M
- IPO Year
- RGS 1991
- VYNE 2018
- Fundamental
- Price
- RGS $16.99
- VYNE $1.85
- Analyst Decision
- RGS
- VYNE Strong Buy
- Analyst Count
- RGS 0
- VYNE 2
- Target Price
- RGS N/A
- VYNE $6.88
- AVG Volume (30 Days)
- RGS 13.5K
- VYNE 224.4K
- Earning Date
- RGS 04-30-2025
- VYNE 05-08-2025
- Dividend Yield
- RGS N/A
- VYNE N/A
- EPS Growth
- RGS N/A
- VYNE N/A
- EPS
- RGS 40.46
- VYNE N/A
- Revenue
- RGS $191,336,000.00
- VYNE $501,000.00
- Revenue This Year
- RGS N/A
- VYNE N/A
- Revenue Next Year
- RGS N/A
- VYNE N/A
- P/E Ratio
- RGS $0.46
- VYNE N/A
- Revenue Growth
- RGS N/A
- VYNE 18.16
- 52 Week Low
- RGS $3.87
- VYNE $1.44
- 52 Week High
- RGS $35.50
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- RGS 44.51
- VYNE 53.21
- Support Level
- RGS $15.75
- VYNE $1.76
- Resistance Level
- RGS $17.81
- VYNE $1.93
- Average True Range (ATR)
- RGS 1.41
- VYNE 0.16
- MACD
- RGS 0.14
- VYNE 0.06
- Stochastic Oscillator
- RGS 47.04
- VYNE 83.67
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.